Doctors test new wearable for back pain: will they use it?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Any treating clinician at a recruiting tertiary pain clinic will be eligible to participate. Patient participants must meet the following criteria: Inclusion Criteria: * Ambulatory * Diagnosis of chronic low back pain (cLBP) according to the criteria of National Institute of Health (NIH) Task Force on Research Standards for cLBP * Answering 'Yes' to the question: Does your low back pain interfere with your mobility? * Starting any new non-surgical treatment or combination of treatments for cLBP as part of their normal ongoing care, including medications; physical therapy/exercise; integrated therapies (e.g., massage, acupuncture, yoga); cognitive- behavioral therapy; and/or interventional procedures (e.g., epidural steroid or facet joint injections) * Willingness to wear a VERABAND™ continuously until their next clinic visit and return used devices in the mail. Exclusion Criteria: * Clinical findings suggesting the presence of ongoing systemic disease, including fever, weight loss, initiation of pain following major trauma, immunosuppression, intravenous drug use, recent bacterial infection, severe or persistent sensory or motor involvement of bowel, bladder, or lower extremity; or any condition that would greatly limit physical activity not due to pain. * Inability to speak and write English. * Visual or hearing difficulties that would preclude participation. * Severe psychiatric disorders that in the opinion of the investigative team would interfere with participation in the study. This includes any active suicidal ideations or history of suicide attempts. Exclusions will be based on self-reported medical history or chart review and in accordance with Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria. * Individuals receiving disability or compensation or involved in litigation. * Scheduled surgery before follow-up.